CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists

P Acien, Pedro Acién, R W Shaw, Robert W. Shaw, L Irvine, L. M. Irvine, G. D. Burford, G Burford, R Gardner, Rosemary Gardner
European journal of obstetrics, gynecology, and reproductive biology · 1989 · vol. 32(3) , pp. 241–246 · doi:10.1016/0028-2243(89)90042-7 · PMID:2676640 · W1973394935
article OA: closed CC0 ⤵ 10 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This paper investigated changes in CA 125 levels in endometriosis patients receiving Danazol or LHRH agonist treatments and analyzed the correlation between these changes and treatment outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antigens, Tumor-Associated, Carbohydrate Danazol Endometriosis Gonadotropin-Releasing Hormone Pregnadienes Adult Antigens, Tumor-Associated, Carbohydrate Danazol Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Pregnadienes

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (10)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:10.744835+00:00
License: CC0 · commercial use OK